Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-25365
Publication type: Article in scientific journal
Type of review: Peer review (publication)
Title: Cost-utility analysis of thumb carpometacarpal resection arthroplasty : a health economic study using real-world data
Authors: Grobet, Cécile
Audigé, Laurent
Eichler, Klaus
Meier, Flurina
Marks, Miriam
Herren, Daniel B.
et. al: No
DOI: 10.1016/j.jhsa.2022.01.013
10.21256/zhaw-25365
Published in: Journal of Hand Surgery (American Volume)
Volume(Issue): 47
Issue: 5
Page(s): 445
Pages to: 453
Issue Date: 2022
Publisher / Ed. Institution: Elsevier
ISSN: 0363-5023
1531-6564
Language: English
Subjects: Cost-effectiveness; Cost-utility; Quality of life; Thumb carpometacarpal osteoarthritis
Subject (DDC): 362.1041: Health economics
617.5: Orthopaedic surgery
Abstract: Purpose: Knowledge about the costs and benefits of hand surgical interventions is important for surgeons, payers, and policy makers. Little is known about the cost-effectiveness of surgery for thumb carpometacarpal osteoarthritis. The objective of this study was to examine patients’ quality of life and economic costs, with focus on the cost-utility ratio 1 year after surgery for thumb carpometacarpal osteoarthritis compared with that for continued nonsurgical management. Methods: Patients with thumb carpometacarpal osteoarthritis indicated for resection arthroplasty were included in a prospective study. The quality of life (using European Quality of Life-5 Dimensions-5 Level), direct medical costs, and productivity losses were assessed up to 1 year after surgery. Baseline data at recruitment and costs sustained over 1 year before surgery served as a proxy for nonsurgical management. The total costs to gain 1 extra quality-adjusted life year and the incremental cost-effectiveness ratio were calculated from a health care system and a societal perspective. Results: The mean European Quality of Life-5 Dimensions-5 Level value for 151 included patients improved significantly from 0.69 to 0.88 (after surgery). The productivity loss during the preoperative period was 47% for 49 working patients, which decreased to 26% 1 year after surgery. The total costs increased from US $20,451 in the preoperative year to US $24,374 in the postoperative year. This resulted in an incremental cost-effectiveness ratio of US $25,370 per quality-adjusted life year for surgery compared with that for simulated nonsurgical management. Conclusions: The calculated incremental cost-effectiveness ratio was clearly below the suggested Swiss threshold of US $92,000, indicating that thumb carpometacarpal surgery is a cost-effective intervention.
URI: https://digitalcollection.zhaw.ch/handle/11475/25365
Fulltext version: Accepted version
License (according to publishing contract): CC BY-NC-ND 4.0: Attribution - Non commercial - No derivatives 4.0 International
Restricted until: 2023-05-01
Departement: School of Management and Law
Organisational Unit: Winterthur Institute of Health Economics (WIG)
Appears in collections:Publikationen School of Management and Law

Files in This Item:
File Description SizeFormat 
2022_Grobet-etal_Cost-utility-analysis-thumb-carpometacarpal.pdf
  Until 2023-05-01
525.28 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.